Oral Nicotine Product Awareness and Use among People who Smoke and Vape in the U.S.
Thursday, June 16, 2022
Posted by: Natalia Gromov
Felicione
NJ, Schneller LM, Goniewicz ML, et al.
Oral Nicotine Product
Awareness and Use among People who Smoke and Vape in the U.S.
[published online ahead of print, 2022 Jun 3]. Am J Prev Med.
2022;S0749-3797(22)00243-4. doi:10.1016/j.amepre.2022.04.019
Introduction.
Tobacco-free oral nicotine products are an emerging class of noncombustible
nicotine products. Oral nicotine product sales have increased since 2016,
although little research has investigated consumer awareness, use, or
correlates of oral nicotine product use. The purpose of this analysis was to
assess the prevalence and correlates of oral nicotine product awareness and
use.
Methods.
This paper is a cross-sectional analysis of 2,507 U.S. participants from Wave 3
(February-June 2020) of the International Tobacco Control Four Country Smoking
and Vaping Survey, a population-based survey of current and former cigarette
smokers and nicotine vaping product users in the U.S. Oral nicotine product
awareness and use prevalence were compared with those of heated tobacco
products. Analyses conducted in late 2021 assessed the correlates of oral
nicotine product awareness and use such as demographic characteristics, tobacco
use (cigarettes, nicotine vaping products, smokeless tobacco), and tobacco quit
attempts.
Results.
Almost 1 in 5 respondents claimed to have heard of oral nicotine products, 3.0%
reported ever use, and 0.9% were current users, all of which were lower than for
heated tobacco products. Ever use of oral nicotine products was more common
among younger adults (e.g., aged 18-24 years), males, and current users of
smokeless tobacco. Oral nicotine product prevalence was higher among those who
reported having made attempts to stop smoking or vaping.
Conclusions.
Oral nicotine product use was low among current and former smokers and nicotine
vaping product users. Oral nicotine product users were demographically similar
to use among individuals who smoke/vape and also use smokeless tobacco. Future
studies are needed to understand emerging oral nicotine products, particularly
whether they are being used as product supplements (dual use), replacements
(switching), or cessation aids (quitting).
|
|
Email to a Friend